Analyst Expectations For Immunocore Hldgs's Future
Portfolio Pulse from Benzinga Insights
Analysts have mixed views on Immunocore Holdings (NASDAQ: IMCR) with a majority being bullish. The average 12-month price target has increased by 7.21% to $81.79. Recent analyst actions include maintaining, raising, and lowering ratings and price targets.
May 24, 2024 | 1:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Analysts have mixed views on Immunocore Holdings with a majority being bullish. The average 12-month price target has increased by 7.21% to $81.79, indicating positive sentiment.
The majority of analysts are bullish on IMCR, and the average price target has increased, indicating positive sentiment. This is likely to have a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100